ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: PP06

Collaborative Advocacy Helps Me and Other Patients With Relapsing Polychondritis (“RP”’) /  My life improved by helping the RP Foundation and Race for RP facilitate awareness, education, and research to improve the quality of life for patients with RP and advance a cure for this disease.

Michael Linn1 and Dan Smith2, 1Relapsing Polychondritis Foundation, New York, NY, 2Relapsing Polychondritis Foundation, Canton, MI

Meeting: ACR Convergence 2021

Keywords: autoimmune diseases, cartilage, Cartilage Degradation, Community programs, education, patient

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 7, 2021

Title: Patient Perspectives Poster (PP01–PP09)

Session Type: Poster Session B

Session Time: 8:30AM-10:30AM

Background/Purpose: In March 2020, I was diagnosed as having relapsing polychondritis (“RP”), an understudied, underdiagnosed, and undertreated debilitating autoimmune disease that can be fatal if left untreated. The disease affects multiple organ, particularly cartilaginous structures such as the ears, nose, airways, joints, as well as the eyes, skin, heart valves, and brain. The cause of RP remains unknown, and consequently, there is not a diagnostic test or targeted treatment options for patients with RP.

Intervention: Since the early stages of my diagnosis, the RP Foundation (www.polychondritis.org) has continued to be a tremendous resource. Soon after my diagnosis, they provided educational materials and introductions to RP experts and an online RP support group. The RP Foundation also connected me to Race for RP (www.RaceForRP.org), which supports research, awareness programs, and care for those who are affected by RP.

From these connections, the importance of working as a team became particularly clear. Celebrating the successes and supporting teammates through the losses applies to sports, managing patient care, conducting research programs, and educating others about autoimmune diseases.

Maintenance: While fighting RP, I was inspired by the RP advocates that I met. So, I volunteered to be the primary liaison between the leading RP social media platforms (including the RP Foundation and Race for RP) and a large, private online support group.

Quality of Life: My life has been significantly improved by being part of a successful team whose purpose is to facilitate awareness, education, and research to improve the quality of life for patients with RP and advance a cure for this disease. It provides me with the opportunity to help others and be excited about the extraordinary advances in patient care and cutting-edge research. I enjoy being an active and helpful member of a successful team.

Dan & Debbie Smith with Race for RP car

Race for RP

Relapsing Polychondritis Foundation


Disclosures: M. Linn, None; D. Smith, None.

To cite this abstract in AMA style:

Linn M, Smith D. Collaborative Advocacy Helps Me and Other Patients With Relapsing Polychondritis (“RP”’) /  My life improved by helping the RP Foundation and Race for RP facilitate awareness, education, and research to improve the quality of life for patients with RP and advance a cure for this disease. [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/collaborative-advocacy-helps-me-and-other-patients-with-relapsing-polychondritis-rp-my-life-improved-by-helping-the-rp-foundation-and-race-for-rp-facilitate-awaren/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/collaborative-advocacy-helps-me-and-other-patients-with-relapsing-polychondritis-rp-my-life-improved-by-helping-the-rp-foundation-and-race-for-rp-facilitate-awaren/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology